C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Open Access
- 1 October 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 131 (4) , 1930-1935
- https://doi.org/10.4049/jimmunol.131.4.1930
Abstract
Examination of C3b deposition on the surface of activators during alternative pathway activation revealed three temporal phases: a lag phase, an amplification phase, and a heretofore uncharacterized plateau phase. During the plateau phase no C3b deposition appeared to occur even in the presence of an excess of alternative pathway components. Double label experiments, however, revealed that the plateau was a steady state between continued C3b deposition and release of C3b or C3bi from the activator. Under conditions of excess complement it was found that deposition of increasing numbers of C3b molecules caused a gradual increase in the ability of Factors H and I to inactivate newly deposited C3b; i.e., the deposited C3b converted the activator into a nonactivator. The data indicate that the surface of rabbit erythrocytes is rendered completely nonactivating when 2.4 X 10(6) molecules of C3b plus C3bi are bound per cell. The plateau of C3b deposition appears to represent the maximum steady state level maintainable by a given concentration of complement components, and it also reflects conversion of an activating surface to one resembling a nonactivator.This publication has 32 references indexed in Scilit:
- Interaction between the third complement protein and cell surface macromolecules.Proceedings of the National Academy of Sciences, 1977
- Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsThe Journal of Experimental Medicine, 1977
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Activation of the alternative complement pathway due to resistance of zymosan-bound.Proceedings of the National Academy of Sciences, 1977
- The role of membrane receptors for C3b and C3d in phagocytosis.The Journal of Experimental Medicine, 1977
- C3- and C5-Cleaving Properdin Enzymes Formed on Zymosan Incubated with Human Serum: the Decay and the Regeneration of the EnzymesInternational Archives of Allergy and Immunology, 1977
- Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.The Journal of Experimental Medicine, 1977
- Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.The Journal of Experimental Medicine, 1976
- THE REACTION MECHANISM OF ß1C-GLOBULIN (C'3) IN IMMUNE HEMOLYSISThe Journal of Experimental Medicine, 1966